1. Home
  2. BIAF vs WETH Comparison

BIAF vs WETH Comparison

Compare BIAF & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • WETH
  • Stock Information
  • Founded
  • BIAF 2014
  • WETH 1992
  • Country
  • BIAF United States
  • WETH China
  • Employees
  • BIAF N/A
  • WETH N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • WETH
  • Sector
  • BIAF Health Care
  • WETH
  • Exchange
  • BIAF Nasdaq
  • WETH Nasdaq
  • Market Cap
  • BIAF 12.2M
  • WETH 10.9M
  • IPO Year
  • BIAF 2022
  • WETH N/A
  • Fundamental
  • Price
  • BIAF $0.35
  • WETH $0.91
  • Analyst Decision
  • BIAF Hold
  • WETH
  • Analyst Count
  • BIAF 1
  • WETH 0
  • Target Price
  • BIAF N/A
  • WETH N/A
  • AVG Volume (30 Days)
  • BIAF 12.3M
  • WETH 65.1K
  • Earning Date
  • BIAF 08-13-2025
  • WETH 08-18-2025
  • Dividend Yield
  • BIAF N/A
  • WETH N/A
  • EPS Growth
  • BIAF N/A
  • WETH N/A
  • EPS
  • BIAF N/A
  • WETH 0.34
  • Revenue
  • BIAF $8,809,228.00
  • WETH $41,024,264.00
  • Revenue This Year
  • BIAF N/A
  • WETH N/A
  • Revenue Next Year
  • BIAF $20.00
  • WETH N/A
  • P/E Ratio
  • BIAF N/A
  • WETH $2.68
  • Revenue Growth
  • BIAF 78.40
  • WETH 2.86
  • 52 Week Low
  • BIAF $0.16
  • WETH $0.76
  • 52 Week High
  • BIAF $2.99
  • WETH $2.96
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 56.35
  • WETH 44.44
  • Support Level
  • BIAF $0.27
  • WETH $0.86
  • Resistance Level
  • BIAF $0.38
  • WETH $0.97
  • Average True Range (ATR)
  • BIAF 0.04
  • WETH 0.08
  • MACD
  • BIAF 0.01
  • WETH -0.00
  • Stochastic Oscillator
  • BIAF 73.43
  • WETH 26.32

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.

Share on Social Networks: